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An investigation of nitrile transforming enzymes
in the chemo-enzymatic synthesis of the
taxol sidechain†
Birgit Wilding,a Alicja B. Veselá,b Justin J. B. Perry,c Gary W. Black,c Meng Zhang,c
Ludmila Martínkováb and Norbert Klempier*a
Paclitaxel (taxol) is an antimicrotubule agent widely used in the treatment of cancer. Taxol is prepared in a
semisynthetic route by coupling the N-benzoyl-(2R,3S)-3-phenylisoserine sidechain to the baccatin III
core structure. Precursors of the taxol sidechain have previously been prepared in chemoenzymatic
approaches using acylases, lipases, and reductases, mostly featuring the enantioselective, enzymatic step
early in the reaction pathway. Here, nitrile hydrolysing enzymes, namely nitrile hydratases and nitrilases,
are investigated for the enzymatic hydrolysis of two diﬀerent sidechain precursors. Both sidechain precur-
sors, an openchain α-hydroxy-β-amino nitrile and a cyanodihydrooxazole, are suitable for coupling to
baccatin III directly after the enzymatic step. An extensive set of nitrilases and nitrile hydratases was
screened towards their activity and selectivity in the hydrolysis of two taxol sidechain precursors and their
epimers. A number of nitrilases and nitrile hydratases converted both sidechain precursors and their
epimers.
Introduction
Paclitaxel (taxol) is a complex natural compound used in anti-
cancer therapy against a variety of cancers, such as ovarian,
gastric, head and neck, non-small lung, prostate and breast
cancer.1–4 Taxol was first isolated from the bark of the pacific
yew Taxus brevifolia, following an initiative of the US National
Cancer Institute (NCI), screening for antineoplastic activity of
new substances from various origins.1,5
Taxol acts as microtubule stabilizer, binding to tubulin in
polymerized microtubules, disrupting the cell cycle, ultimately
leading to cell death.6–8 Despite its known limitations, e.g.,
poor solubility, toxicities and emerging drug resistance, taxol
is still widely used in cancer therapy. New administration
forms, formulations and taxane analogues have been designed
to overcome selectivity, eﬃcacy, toxicity and drug resistance
issues.9–11 Numerous eﬀorts have been made to determine the
structure activity relationship of taxol.12 In recent years, the
role of the (2R,3S)-N-benzoyl-3-phenylisoserine C-13 sidechain
had been confirmed as essential for the biological activity of
taxol (Fig. 1).13
Various sidechain precursors have been prepared in
asymmetric chemical syntheses14 and in chemoenzymatic
approaches15 using acylases,16 lipases17 and reductases.18
In this work, nitrile transforming enzymes, namely nitri-
lases and nitrile hydratases, are investigated for the synthesis
of the taxol sidechain. Nitrilases (EC 3.5.5.1) and nitrile hydra-
Fig. 1 Structure of Paclitaxel (taxol), consisting of the baccatin III core
structure and the (2R,3S)-N-benzoyl-3-phenylisoserine C-13 sidechain.
†Electronic supplementary information (ESI) available: NMR spectra of all com-
pounds, experimental procedures for acid and amide reference materials, repre-
sentative HPLC chromatograms of biotransformation reactions from non-chiral
and chiral HPLC measurements, biotransformations with cosolvents, infor-
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tases (EC 4.2.1.84) are attractive biocatalysts for the fine chemi-
cals and pharmaceutical industries. Nitrilases catalyse the
cleavage of nitriles to the corresponding carboxylic acids and
ammonia and have been shown to catalyse the hydrolysis of a
variety of nitriles, including the enantioselective synthesis of
β-amino acids from β-amino nitriles.19 However, several nitri-
lases were reported to convert nitriles to both, acid and amide
products (Scheme 1).20 Nitrile hydratases are Fe- or Co-metallo-
enzymes that catalyse the hydration of nitriles to their corres-
ponding amides.21 To the best of our knowledge, nitrilases
have not yet been investigated in the synthesis of the taxol
sidechain. Previously, a nitrile hydratase from Debaryomyces
hansenii DSM 3428 was used in whole cell experiments for the
hydration of (±)-trans-3-phenyloxirane-2-carbonitrile. The reac-
tion proceeded with low enantioselectivity (ee-value <36%),
despite stopping the reaction shortly before 50% conversion
was achieved.15b
Here, two diﬀerent taxol sidechain precursors were pre-
pared in chemical synthesis, an openchain α-hydroxy-β-amino
nitrile and a cyanodihydrooxazole. A set of 24 nitrilases and
four nitrile hydratases was investigated for the biotransform-
ation of these taxol sidechain precursors and their epimers.
The enzymatic hydrolysis of these nitrile containing sidechain
precursors applies the stereoselective, enzyme-catalysed reac-
tion as the last step in the synthesis.
Results and discussion
Two diﬀerent taxol sidechain precursors were prepared in
chemical synthesis, as depicted in Scheme 2. The corres-
ponding acids and amides were prepared in chemical syn-
thesis as reference materials for the biotransformation
reactions.22 In the first synthetic step, benzaldehyde was trans-
formed to a mixture of (±)-cis- and (±)-trans-3-phenyloxirane-
2-carbonitrile in a Darzens reaction.23 The epimers were separ-
ated by column chromatography and used separately to syn-
thesise the dihydrooxazoles (±)-trans-1 and (±)-cis-1 in a Ritter-
type reaction.24 Ring opening under acidic conditions gave the
openchain precursors (±)-syn-2 and (±)-anti-2.
The sidechain precursors (±)-trans-1 and (±)-syn-2 and their
epimers were investigated as substrates for a set of diﬀerent
nitrile hydratases and nitrilases (Scheme 1 and 2). Both side-
chain precursors, (±)-trans-1 and the cyanohydrin (±)-syn-2
were stable under the reaction conditions of the biotransform-
ation reactions, as confirmed in blank reactions.25 All biotrans-
formation reactions (nitrilase and nitrile hydratase catalysed
reactions) were evaluated in a HPLC-(MS) based screening,
using acid and amide references prepared in chemical syn-
thesis.22 Commercially available, easy to use nitrile hydratases
from Prozomix, Ltd (PRO-E0257 to PRO-E0259)26 were used.
Nitrilases included 18 commercially available nitrilases from
two diﬀerent suppliers, namely Codexis, Inc. (NIT-101 to
NIT-114)27 and Prozomix, Ltd (PRO-E0260 to PRO-E0264)26
and six fungal nitrilases overexpressed in E. coli.28
The openchain precursor (±)-syn-N-(2-cyano-2-hydroxy-
1-phenylethyl)benzamide, (±)-syn-2, and its epimer (±)-anti-N-
(2-cyano-2-hydroxy-1-phenylethyl)benzamide, (±)-anti-2, were
readily hydrolysed by three out of four nitrile hydratases
tested, as summarised in Table 1. Conversions for (±)-anti-2
were higher than for (±)-syn-2. Examination of the amino acid
Scheme 2 Synthesis of the taxol sidechain precursors (±)-trans-1 and
(±)-syn-2. The epimers (±)-cis-1 and (±)-anti-2 were prepared analo-
gously; (i) benzonitrile, BF3*Et2O, (ii) 1 M aq. HCl, methanol, 60 °C.
(±)-cis- and (±)-trans-3-Phenyloxirane-2-carbonitrile were prepared
from benzaldehyde as described in the ESI.†
Scheme 1 Enzymatic conversion of the taxol sidechain precursor
(±)-trans-1 to the corresponding carboxylic acid and/or carboxamide.
Nitrilase and nitrile hydratase catalysed reactions were investigated for
the taxol sidechain precursors (±)-trans-1 and (±)-syn-2 and their
epimers (±)-cis-1, and (±)-anti-2.
Table 1 Screening results of (±)-syn-2, (±)-syn-N-(2-cyano-2-hydroxy-
1-phenylethyl)benzamide, and its epimer (±)-anti-2 with commercially
available nitrile hydratases. Reaction time 22 h, substrate concentration
0.4 mM, 200 µL commercial enzyme preparation, total volume 500 µL
(ref. 26)
Nitrile
hydratase
Conversion of
(±)-syn-2 to
amide [%]
Conversion of
(±)-anti-2 to
amide [%]
PRO-E0256 0 0
PRO-E0257 5.8 15.8
PRO-E0258 12.5 42.0
PRO-E0259 37.1 53.7
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sequences of the nitrile hydratases26 indicated that Co-type
nitrile hydratases (PRO-E0257, PRO-E0258, PRO-E0259), but
not the Fe-type nitrile hydratase (PRO-E0256) catalysed this
reaction.
Less than one third of the commercially available nitrilases
catalysed the hydrolysis of (±)-syn-N-(2-cyano-2-hydroxy-1-phenyl-
ethyl)benzamide, (±)-syn-2. Of these five nitrilases, NIT-106
and NIT-114 gave carboxamide, 23% and 15% conversion
(after 15 hours) respectively, as the only product. Two other
nitrilases, NIT-111 and PRO-E0260, yielded the desired car-
boxylic acid as product, however also gave significant amounts
of amide as the by-product, as depicted in Fig. 2. A single nitri-
lase, PRO-E0263, yielded the desired carboxylic acid and only
minor amounts (less than 10%) of the amide by-product.
(±)-syn-2 was not hydrolysed by any of the fungal nitrilases
tested.
(±)-anti-N-(2-Cyano-2-hydroxy-1-phenylethyl)benzamide,
(±)-anti-2, was accepted by similar nitrilases as (±)-syn-2, as
depicted in Fig. 3. NIT-106 gave the amide as the main
product, NIT-111 and PRO-E0260 gave almost equal amounts
of the acid and amide throughout the reaction time, as
depicted in Fig. 3. PRO-E0263 gave the best results for the
hydrolysis of (±)-anti-2, yielding the carboxylic acid as the only
product. (±)-anti-2 was not hydrolysed by any of the fungal
nitrilases tested.
Nitrilases PRO-E0260 and PRO-E0264 are nitrilases from
Bradyrhizobium japonicum. Nitrilase PRO-E0260 is an arylaceto-
nitrilase and exhibits its highest activity for (R,S)-mandelo-
nitrile but did not show enantioselectivity.29 PRO-E0260
hydrolysed (±)-syn-2 and (±)-anti-2, however, gave almost equal
amounts of the acid and amide as products. PRO-E0264 has
little activity towards branched nitriles, such as mandelo-
nitrile, its preferential substrates being, e.g. hydrocinnamonitrile
and heptanenitrile.30 No activity of PRO-E0264 was observed
towards (±)-syn-2 and (±)-anti-2.
The dihydrooxazole (±)-trans-1, (±)-trans-2,4-diphenyl-4,5-
dihydrooxazole-5-carbonitrile, was chosen as the second side-
chain precursor. Here, the enantioselective α-hydroxy-β-amino
nitrile moiety is protected in a cyclic precursor. The corres-
ponding carboxylic acid of (±)-trans-1 can be directly coupled
to baccatin III. The final cleavage of the dihydrooxazole ring
occurs subsequently under defined acidic conditions.31
The dihydrooxazoles (±)-cis-1 and (±)-trans-1 were hydro-
lysed by all nitrile hydratases tested. Good conversions and ee-
values were achieved for the hydration of (±)-cis-1 (Table 2).
Biotransformations of (±)-trans-1 gave higher, almost quanti-
tative, conversions with all nitrile hydratases, even when reac-
tion time and concentration of enzyme were significantly
decreased. Quantitative conversions, however, indicate poor
enantioselectivity of these nitrile hydratase catalysed reactions.
Only two nitrilases, of the 15 commercial nitrilases and six
fungal nitrilases tested, hydrolysed (±)-cis-1, and both gave
amide as the major product (Fig. 4). In contrast to (±)-cis-1, the
sidechain precursor (±)-trans-1 was hydrolysed by half of the
Fig. 3 Screening results of (±)-anti-2, (±)-anti-N-(2-cyano-2-hydroxy-
1-phenylethyl)benzamide, 0.4 mM, with commercially available nitri-
lases. NIT-101–NIT-105, NIT-108, NIT-112 to NIT-114, PRO-E0261,
PRO-E0262 and PRO-E0264 gave no conversion. None of the fungal
nitrilases tested hydrolysed (±)-anti-2.
Table 2 Screening results of (±)-trans-1, (±)-trans-2,4-diphenyl-
4,5-dihydrooxazole-5-carbonitrile, 0.4 mM, and its epimer (±)-cis-1
(0.4 mM) with commercially available nitrile hydratases
Enzyme
Conversion of (±)-cis-1 to
amide [%]; ee-valuea [%]
Conversion of (±)-trans-1
to amidea [%]
PRO-E0256 31.7; 65.2 91.7
PRO-E0257 51.6; 83.4 93.7
PRO-E0258 63.2; 87.6 96.9
PRO-E0259 74.4; 90.9 100
a (±)-cis-1: 200 µL commercial enzyme preparation, reaction time 21 h,
(±)-trans-1: 50 µL commercial enzyme preparation.26 Total volume 500
µL. Results for additional enzyme concentrations and reaction times
are available in the ESI.
Fig. 2 Screening results of (±)-syn-2, (±)-syn-N-(2-cyano-2-hydroxy-1-
phenylethyl)benzamide, 0.4 mM, with commercially available nitrilases
(4 mg mL−1 commercial enzyme preparation in buﬀer). NIT-101 to
NIT-105, NIT-108, NIT-112, NIT-113, PRO-E0261, PRO-E0262 and
PRO-E0264 gave no conversion, NIT-106 and NIT-114 gave amide as
only product. None of the fungal nitrilases tested hydrolysed (±)-syn-2.
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commercially available nitrilases and all the fungal nitrilases
tested (Fig. 5–7).
Nine diﬀerent commercially available nitrilases accepted
(±)-trans-2,4-diphenyl-4,5-dihydrooxazole-5-carbonitrile, (±)-trans-1
as the substrate. Reactions giving similar amounts of acid and
amide are summarised in Fig. 5, while reactions giving
carboxylic acid as main product are summarised in Fig. 6.
NIT-106, NIT-108 and NIT114 gave 15–25% of amide by-
product after 15 hours reaction time, NIT-105, NIT-111 and
PRO-E0260 gave only minor amounts of less than 10% of
amide by-product.
(±)-trans-2,4-Diphenyl-4,5-dihydrooxazole-5-carbonitrile, (±)-trans-1,
was hydrolysed to the carboxylic acid by all six fungal
nitrilases, as depicted in Fig. 7. The nitrilases from Aspergillus
oryzae, Neurospora crassa, and Nectria haematococca produced
both carboxylic acid and amide throughout the reaction time.
The nitrilases from Arthoderma benhamiae and Aspergillus niger
Fig. 4 Screening results of (±)-cis-1, (±)-cis-2,4-diphenyl-4,5-di-
hydrooxazole-5-carbonitrile, 0.4 mM, with commercially available nitri-
lases (4 mg mL−1 commercial enzyme preparation in buﬀer). None of
the fungal nitrilases tested hydrolysed (±)-cis-1.
Fig. 5 Screening results of (±)-trans-1, (±)-trans-2,4-diphenyl-4,5-
dihydrooxazole-5-carbonitrile, 0.4 mM, with commercially available
nitrilases (4 mg mL−1 commercial enzyme preparation in buﬀer).
NIT-102, NIT-104, PRO-E0263, giving similar amounts of acid and amide
as products.
Fig. 6 Screening results of (±)-trans-1, (±)-trans-2,4-diphenyl-4,5-dihydrooxazole-5-carbonitrile, 0.4 mM, with commercially available nitrilases
giving the acid as the main product (4 mg mL−1 commercial enzyme preparation in buﬀer). NIT-101, NIT-103, NIT-109, NIT-110, NIT-112, NIT-113,
PRO-E0261, PRO-E0262 and PRO-E0264 gave no conversion, NIT-102, NIT-104 and PRO-E0263 gave similar amounts of acid and amide products,
as summarized in Fig. 5.
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hydrolysed (±)-trans-1 to the carboxylic acid at the beginning
of the reaction, amide was only formed after approximately
25% conversion to the acid.
All fungal nitrilases used here were previously characterised
as arylacetonitrilases with preference for phenylacetonitrile
and (R,S)-mandelonitrile as substrates. Their similar substrate
specificities correspond with considerable identities of their
amino acid sequences (mostly over 50%). Nevertheless, diﬀer-
ences have previously been observed between their specific
activities, enantioselectivities and chemoselectivities for (R,S)-
mandelonitrile.28,32
The ee-values obtained in the nitrilase catalysed reactions
of (±)-trans-1 were below 80%.33 The moderate ee-values might
be explained by a number of reasons. Racemisation and/or epi-
merisation of the compounds might occur during or after the
biotransformation. Stopping the reaction by precipitating the
enzyme might not have been eﬃcient enough, as the protein
might not have been quantitatively precipitated. Reactions
could be most eﬃciently stopped by using immobilized
enzyme which can be easily removed from the reaction
mixture. In commercially available enzymes, additives in the
enzyme preparation might influence enantioselectivity and
ratio of the acid and amide products. The additive dithiothrei-
tol (DTT) is added to nitrilases to prevent disulphide bond for-
mation of the catalytically active cysteine, though it has been
previously proven to catalyse the non-stereoselective hydrolysis
of nitriles to amides.34 In recent examples, the presence of
organic solvents has been shown to enhance activity and
stereoselectivity in nitrilase catalysed biotransformations.35
The influence of organic solvents on enzymatic nitrile hydro-
lysis is poorly studied so far, especially compared to other
hydrolytic enzymes, such as lipases and esterases.36 Influences
on the stereoselectivity of the nitrilase and nitrile hydratase
catalysed reactions need to be further investigated to achieve a
reliable nitrile transforming biocatalyst for the synthesis of the
taxol sidechain.
A preparative scale biotransformation of (±)-trans-1 was
carried out with with whole cells of E. coli expressing the nitri-
lase from Neurospora crassa OR74A. Approximately 50% con-
version of (±)-trans-1 were achieved after three hours. However,
the enantioselectivity of the reaction was not satisfactory, with
an er37 of 1/1.6 (4S,5R)-2,4-diphenyl-4,5-dihydro-1,3-dihydro-
1,3-oxazole-5-carboxylic acid to enantiomer.
Conclusions
In this work, an extensive set of nitrilases and nitrile hydra-
tases was screened towards their activity and selectivity in the
hydrolysis of two taxol sidechain precursors and their epimers.
Both sidechain precursors were designed to utilize the enzy-
matic step as final step in the synthesis. A number of nitrilases
and nitrile hydratases catalysed the biotransformation of both
sidechain precursors and their epimers.
All nitrilases and nitrile hydratases tested showed similar
substrate specificity towards the taxol sidechain precursor
(±)-syn-N-(2-cyano-2-hydroxy-1-phenylethyl)benzamide (±)-syn-2,
and its epimer (±)-anti-2. The openchain compounds
(±)-syn-2 and (±)-anti-2 were converted by all Co-type nitrile
hydratases tested, while the Fe-type nitrile hydratase
PRO-E0256 did not convert (±)-syn-2 or (±)-anti-2. Three com-
mercially available nitrilases were found that hydrolyse the
Fig. 7 Screening results of (±)-trans-2,4-diphenyl-4,5-dihydrooxazole-5-carbonitrile (1.0 mM) with fungal nitrilases (9.5 mL cell suspension of
appropriate optical density in 100 mL buﬀer).
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openchain precursor (±)-syn-2. Nitrilase PRO-E0263 gave less
than 10% of amide by-product. The same nitrilases also hydro-
lysed (±)-anti-2. Here, PRO-E0263 produced the desired
carboxylic acid as only product from (±)-anti-2.
(±)-cis- and (±)-trans-2,4-Diphenyl-4,5-dihydrooxazole-5-
carbonitrile, (±)-cis-1 and (±)-trans-1, were excellent substrates
for all Co- and Fe-nitrile hydratases tested, giving the corres-
ponding amides in 30–100% yield. The substrate specificity of
nitrilases towards (±)-trans-1 and its epimer (±)-cis-1 diﬀered
quite drastically. Only two of 23 nitrilases accepted (±)-cis-1 as
substrate, the amide was the major product formed. The
epimer (±)-trans-1, however, was converted by 18 diﬀerent
nitrilases, where three nitrilases gave similar amounts of acid
and amide as product, and the remaining 15 gave the desired
carboxylic acid as main product. Three commercially available
nitrilases (NIT-105, NIT-111, PRO-E0260) gave less than 10% of
amide by-product, four of the six fungal nitrilases (Arthoderma
benhamiae, Aspergillus niger, Neurospora crassa, Aspergillus
oryzae) gave less than 20% of amide by-product.
Fungal nitrilases, first of all arylacetonitrilases, have almost
been neglected until recently due to their low production in
wild-type strains, but genome mining has enabled the discov-
ery of the first enzymes of this type. Their biocatalytic potential
was confirmed with a new type of nitrile substrates in this
work, and indicated further screening of this enzyme group
would be promising.
This work presents the first investigation of nitrilases as
tools for the chemo-enzymatic synthesis of the taxol sidechain.
Nitrile hydratases (especially Co-type nitrile hydratases) and
arylacetonitrilases (both, bacterial and fungal) were found to
be suitable catalysts for one or both taxol sidechain precursors
tested. The stereoselectivity of the enzyme catalysed reactions
will need to be further investigated and improved for a
possible application of these nitrile transforming enzymes in
an enantioselective, chemo-enzymatic synthesis of the taxol
sidechain.
Experimental
General methods
Thin layer chromatography was carried out with precoated alu-
minium silica gel 60 F254 plates, column chromatography with
Merck Silica Gel 60 (0.040–0.063 mm). 1H NMR and 13C NMR
spectra were recorded on a Bruker AVANCE III with auto-
sampler (1H NMR 300.36 MHz, 13C NMR 75.53 MHz). Chemical
shifts for 1H NMR are reported in ppm relative to Me4Si as
internal standard. Assignments were supported by HSQC and/
or HMBC measurements. For all screening reactions, including
blank reactions, multiple parallel determinations (at least two)
were run. HPLC-MS analysis was carried out on an Agilent
1200 series using a Merck Purospher STAR® (RP-18e, 5 µm,
LiChroCART® 250-4) column (flow 0.9 mL min−1, injection
10 µL) or on a Waters 600 with a PDA detector 996 using a
Chromolith® SpeedROD RP-18 endcapped 50-4.6 column
(flow 2 mL min−1, injection 10 µL), and 0.1% v/v acetic acid in
water and acetonitrile as eluents. Determination of ee-values
was performed by HPLC analysis on an Agilent 1100 series
using a Chiralpak AD-H (Daicel Chemical Industries, Ltd,
0.46 cm × 25 cm) column, ethanol as eluent, flow 0.55 mL
min−1, column oven temperature 40 °C or a Chiralpak AGP
column (Daicel Chemical Industries, Ltd, 150 × 4 mm, 5 µm)
and 90% acetate buﬀer (100 mM, pH 4.4), 10% acetonitrile as
eluents, flow 0.9 mL min−1, column oven temperature 25 °C or
a Chiralpak AGP column (Daicel Chemical Industries, Ltd, 150
× 4 mm, 5 µm) 10% iso-propanol and 90% citrate buﬀer
(50 mM, pH 4.4), flow 0.9 mL min−1, column oven 22 °C.25,33
Substrate synthesis
(±)-trans-2,4-Diphenyl-4,5-dihydrooxazole-5-carbonitrile,
(±)-trans-1.34,34 (±)-cis-Phenyloxirane-2-carbonitrile (6.12 g,
42.2 mmol) was dissolved in benzonitrile (129 mL, 1.25 mol)
and cooled to −10 °C. The reaction mixture was stirred under
nitrogen atmosphere. Freshly distilled boron trifluoride
diethyl etherate (5.72 mL, 46.4 mmol) was added and the
resulting mixture was stirred overnight in an ice bath. Sub-
sequently, the solution was basified by addition of saturated
Na2CO3 solution followed by solid Na2CO3. The solution was
then extracted with ethyl acetate three times and the combined
organic layers were washed with brine. The solvent and excess
benzonitrile were removed in vacuum. The product was puri-
fied by column chromatography using cyclohexane/ethyl
acetate 4/1 as eluent. cis-2,4-Diphenyl-4,5-dihydrooxazole-5-carbo-
nitrile was found as side product of the reaction. (±)-trans-
2,4-Diphenyl-4,5-dihydrooxazole-5-carbonitrile was isolated as
a white solid (8.37 g, 80.0%). m.p. 81 °C; EI-HRMS m/z
248.0952 ([M]+, C16H12N2O, calc. 248.0950);
1H NMR (DMSO-
d6) δ 5.75 (1H, d, J = 6.0 Hz, H-5), 5.86 (1H, d, J = 6.0 Hz, H-4),
7.33–7.46 (5H, m, H-2″, H-3″, H-4″), 7.58 (2H, t, J = 7.5 Hz,
H-3′), 7.68 1H, (t, J = 7.4 Hz, H-4′), 8.00 (2H, d, J = 7.8 Hz, H-2′);
13C NMR (DMSO-d6) δ 71.57 (C-5), 74.32 (C-4), 117.76 (CN),
125.50 (C-1′), 126.74 (C-4″), 128.31, 128.43, 128.84, 128.99
(C-2′, C-3′, C-2″, C-3″), 132.65 (C-4′), 138.90 (C-1″), 161.86 (C-2).
(±)-cis-2,4-Diphenyl-4,5-dihydrooxazole-5-carbonitrile, (±)-cis-
1. (±)-cis-1 was prepared from (±)-trans-phenyloxirane-2-carbo-
nitrile (500 mg, 3.44 mmol) analogously to the (±)-trans-
compound. (±)-cis-2,4-Diphenyl-4,5-dihydrooxazole-5-carbo-
nitrile was isolated as a white solid (580 mg, 67.8%). m.p.
104 °C; 1H NMR (DMSO-d6) δ 5.88 (1H, d, J = 10.0 Hz, H-4), 6.22
(1H, d, J = 10.0 Hz, H-5), 7.34–7.50 (5H, m, H-2″, H-3″, H-4″,
H-5″, H-6″), 7.58 (2H, t, J = 7.5 Hz, H-3′, H-5′), 7.68 (1H, t, J = 7.4
Hz, H-4′), 8.00 (2H, d, J = 7.8 Hz, H-2′, H-6′); 13C NMR (DMSO-
d6) δ 71.58 (C-5), 74.90 (C-4), 115.63 (CN), 125.66 (C-1′), 127.31
(C-4″), 128.23, 128.41, 128.55, 128.97 (C-2′, C-3′, C-5′, C-6′, C-2′,
C-3″, C-5″, C-6″), 132.57 (C-4′), 137.31 (C-1″), 162.34 (C-2).
(±)-syn-N-(2-cyano-2-hydroxy-1-phenylethyl)benzamide,
(±)-syn-2. (±)-trans-2,4-Diphenyl-4,5-dihydrooxazole-5-carbo-
nitrile (506 mg, 2.05 mmol) was dissolved in methanol
(21 mL) and aqueous HCl (1 M, 9 mL) was added. The reaction
mixture was stirred for 3.5 hours at 60 °C. Subsequently, the
solvent was reduced in vacuum. The remaining aqueous residue
was diluted with dichloromethane (20 mL). The layers were
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
2/
07
/2
01
5 
16
:5
2:
58
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
separated and the aqueous layer was twice extracted with
dichloromethane. The combined organic layers were washed
with water and dried over Na2SO4. (±)-syn-N-(2-cyano-2-hydroxy-
1-phenylethyl)benzamide was purified by recrystallisation
from cyclohexane/ethyl acetate and isolated as a white solid
(292 mg, 53.8%). 1H NMR (DMSO-d6) δ 5.02 (1H t, J = 7.3 Hz,
H-2), 5.45 (1H, t, J = 8.0 Hz, H-3), 6.93 (1H, d, J = 7.2 Hz, OH),
7.35–7.50 (3H, m, H-3″, H-4″, H-5″), 7.52–7.67 (5H, m, H-3′,
H-4′, H-5′, H-2″, H-6″), 7.96 (2H, d, J = 7.1 Hz, H-2′, H-6′), 9.06
(1H, d, J = 8.6 Hz, NH); 13C NMR (DMSO-d6) δ 56.62 (C-3),
63.75 (C-2), 119.53 (C-1), 127.46, 127.81, 127.90, 128.28, 128.32
(C-2′, C-3′, C-5′, C-6′, C-2″, C-3″, C-4″, C-5″, C-6″), 131.47 (C-4′),
134.09 (C-1′), 138.09 (C-1″), 166.34 (CONH2).
(±)-anti-N-(2-Cyano-2-hydroxy-1-phenylethyl)benzamide,
(±)-anti-2. (±)-anti-N-(2-Cyano-2-hydroxy-1-phenylethyl)benzamide
was prepared analogously from (±)-cis-2,4-diphenyl-4,5-di-
hydrooxazole-5-carbonitrile (295 mg, 1.19 mmol). (±)-anti-2
was isolated as a white solid (201 mg, 63.5%). 1H NMR
(DMSO-d6) δ 4.90 (1H, t, J = 8.8 Hz, H-2), 5.39 (1H, t, J = 9.5 Hz,
H-3), 6.87 (1H, d, J = 7.9 Hz, OH), 7.32–7.47 (3H, m, H-3″, H-4″,
H-5″), 7.51–7.67 (5H, m, H-3′, H-4′, H-5′, H-2″, H-6″), 7.93 (2H,
d, J = 7.2 Hz, H-2′, H-6′), 9.15 (1H, d, J = 9.0 Hz, NH); 13C NMR
DMSO-d6) δ 55.58 (C-3), 63.59 (C-2), 120.15 (C-1), 127.35,
127.74, 127.94, 128.20, 128.38 (C-2′, C-3′, C-5′, C-6′, C-1″, C-2″,
C-3″, C-4″, C-5″, C-6″), 131.58 (C-4′), 134.01 (C-1′), 138.76
(C-1″), 165.92 (CONH2).
Biotransformation reactions
Biotransformation reactions with commercially available
nitrile hydratases. Nitrile hydratases were obtained from Pro-
zomix Ltd (PRO-E0256 to PRO-E0259). Screening reactions
were done in 1.5 mL microcentrifuge tubes using the following
conditions and concentrations: nitrile hydratase suspension
(50 µL–200 µL), and substrate in DMSO (10 µL of a 20 mM
stock solution, end concentration of substrate 0.4 mM, 2% v/v
DMSO), buﬀer (50 mM K2HPO4, pH 8) to achieve a total
volume of 500 µL. Blank reactions contained substrate in
DMSO (0.4 mM, 2% v/v DMSO), and buﬀer (50 mM K2HPO4,
pH 8). The screening reactions were incubated on a thermo-
mixer at 22 °C and 500 rpm, unless stated otherwise. The reac-
tions were stopped by adding methanol (290 µL). The protein
was precipitated by centrifugation and the supernatant was
analysed by HPLC-MS.
Biotransformation reactions with commercially available
nitrilases. Nitrilases from Codexis Inc. (NIT-101 to NIT-106,
NIT-108 to NIT-114) and Prozomix Ltd (PRO-E0260 to
PRO-E0264) were used. Nitrilases were resuspended in buﬀer
(50 mM K2HPO4, pH 8, 4 mg nitrilase in 1 mL buﬀer). Screen-
ing reactions were done in 1.5 mL microcentrifuge tubes using
the following conditions and concentrations: nitrilase suspen-
sion (490 µL), and substrate in DMSO (10 µL of a 20 mM stock
solution, end concentration of substrate 0.4 mM, 2% v/v
DMSO), total volume 500 µL. Blank reactions contained sub-
strate in DMSO (0.4 mM, 2% v/v DMSO), and buﬀer (50 mM
K2HPO4, pH 8). The screening reactions were incubated on
a thermomixer at 30 °C and 800 rpm. The reactions were
stopped by adding methanol (290 µL). The protein was precipi-
tated by centrifugation and the supernatant was analysed by
HPLC-MS.
Biotransformations with fungal nitrilases. The nitrilase
genes from Arthoderma benhamiae CBS112371 (XP_003011330)
(NitAb), Aspergillus oryzae RIB40 (XP_001824712) (NitAo),
Aspergillus niger CBS513.88 (XP_0013973369) (NitAn), Aspergil-
lus niger CBS513.88 (XP_001398633) (NitAn2), Neurospora
crassa OR74A (CAD70472) (NitNc), and Nectria haematococca
mpVI77-13-4 (XP0030_50920) (NitNc) were overexpressed in
E. coli BL21 Gold DE3 and the cells were grown as previously
described.28 4.75 mL of cell suspension of appropriate optical
density (NitAb 66, NitAn 15, NitAn2 21, NitAo 22, NitNc 2 and
NitNh 38) in 50 mM Tris buﬀer with 150 mM NaCl, pH 8.0,
in 5 mL tubes was preincubated for ten minutes at 25 °C and
600 rpm. The reaction was started by addition of 250 µL of
20 mM stock solution of (±)-trans-1 in methanol (end concen-
trations: (±)-trans-1 1 mM, methanol 5% v/v). Blank reactions
were performed in buﬀer without cells under the same con-
ditions. Samples (500 µL of the reaction mixture) were with-
drawn after 5, 10, 20, 40, 60, 90, 120 minutes and 22 hours,
mixed with 600 µL of methanol and then centrifuged for
10 minutes at 13000 rpm. 500 µL of the sample was transferred
into a vial and analysed by HPLC.
Preparative scale biotransformations. Preparative scale bio-
transformations were carried out with whole cells of E. coli
expressing the nitrilase from Neurospora crassa OR74A. Five
parallel biotransformations were run, each in a 250 mL Erlen-
meyer flask, containing 100 mL of 50 mM Tris/HCl buﬀer with
150 mM NaCl, pH 8.0 and (±)-trans-2,4-diphenyl-4,5-dihydroox-
azole-5-carbonitrile, (±)-trans-2 (100 mg, 0.40 mmol) in DMSO
(30% v/v), optical density of the cells approximately 2. The
reactions were stopped after three hours reaction time by
addition of 0.5 M HCl (dropwise addition until pH 3), repre-
senting approximately 50% conversion of the nitrile substrate.
The cells were removed by centrifugation. The supernatant was
extracted with DCM (4 × 50 mL). The combined organic layers
were washed with brine (2 × 100 mL), dried over sodium sul-
phate and reduced in vacuum until dryness. Residual DMSO
was removed by lyophilisation overnight. Yield (crude product,
containing a mixture of acid product and unreacted starting
material) 70 mg. The crude product was purified by column
chromatography using a gradient of chloroform to 15% v/v
methanol in chloroform as eluents. The product was isolated
as an oﬀ-white solid (15.6 mg, 10%, purity 71%, er37 1/1.6
(4S,5R)-acid/enantiomer).33 1H NMR and 13C NMR data were
found in accordance with the reference acid.
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V. Kȓen, Curr. Opin. Chem. Biol., 2010, 14, 130–137;
(c) J.-S. Gong, Z.-M. Lu, H. Li, J.-S. Shi, Y.-M. Zhou and
Z.-H. Xu, Microb. Cell Fact., 2012, 11, 142–160;
(d) J.-S. Gong, Z.-M. Lu, H. Li, J.-S. Shi, Y.-M. Zhou and
Z.-H. Xu, Appl. Microbiol. Biotechnol., 2013, 97, 6603–6611.
Selected articles: (e) D. Williamson, K. Dent, B. Weber,
A. Varsani, J. Frederick, R. Thuku, R. Cameron, J. Heerden,
D. Cowan and B. Sewell, Appl. Microbiol. Biotechnol., 2010,
88, 143–153; (f ) J. E. Raczynska, C. E. Vorgias,
G. Antranikian and W. Rypniewski, J. Struct. Biol., 2011,
173, 294–302; (g) M. Winkler, O. Kaplan, V. Vejvoda,
N. Klempier and L. Martínková, J. Mol. Catal. B: Enzym.,
2009, 59, 243–247; (h) D. Brady, A. Beeton, J. Zeevaart,
C. Kgaje, F. van Rantwijk and R. A. Sheldon, Appl. Micro-
biol. Biotechnol., 2004, 64, 76–85; (i) M. Winkler,
L. Martínkova, A. C. Knall, S. Krahulec and N. Klempier,
Tetrahedron, 2005, 61, 4249–4260.
20 (a) B. C. Fernandes, C. Mateo, C. Kiziak, A. Churma,
J. Wacker, F. van Rantwijk, A. Stolz and R. Sheldon, Adv.
Synth. Catal., 2006, 348, 2597–2603; (b) D. Williamson,
K. Dent, B. Weber, A. Varsani, J. Frederick, R. Thuku,
R. Cameron, J. Heerden, D. Cowan and B. Sewell, Appl.
Microbiol. Biotechnol., 2010, 88, 143–153.
21 Selected references: (a) C. D. Mathew, T. Nagasawa,
M. Kobayashi and H. Yamada, Appl. Environ. Microbiol.,
1988, 54, 1030–1032; (b) S. Prasad and T. C. Bhalla, Bio-
technol. Adv., 2010, 28, 725–741; (c) W. Huang, J. Jia,
J. Cummings, M. Nelson, G. Schneider and Y. Lindqvist,
Structure, 1997, 5, 691–699; (d) S. van Pelt, M. Zhang,
L. Otten, J. Holt, D. Sorotkin, F. van Rantwijk, G. W. Black,
J. J. Perry and R. Sheldon, Org. Biomol. Chem., 2011, 9,
3011–3019.
22 Procedures for the synthesis of the acid and amide
reference materials and characterization data are available
in the ESI.†
23 Selected references: (a) A. Jonczyk and T. Zomerfeld, Tetra-
hedron Lett., 2003, 44, 2359–2361; (b) F. W. Bachelor and
R. K. Bansal, J. Org. Chem., 1969, 34, 3600–3604; (c) G. Liu,
D. Zhang, J. Li, G. Xu and J. Sun, Org. Biomol. Chem., 2013,
11, 900–904; (d) W.-J. Liu, B.-D. Lv and L.-Z. Gong, Angew.
Chem., Int. Ed., 2009, 48, 6503–6506.
24 Selected references: (a) B. D. Feske, I. A. Kaluzna and
J. D. Stewart, J. Org. Chem., 2005, 70, 9654–9657;
(b) X. Deng, J. Su, Y. Zhao, L.-Y. Peng, Y. Li, Z.-J. Yao and
Q.-S. Zhao, Eur. J. Med. Chem., 2011, 46, 4238–4244;
(c) M. V. Voronkov, A. V. Gontcharov, Z.-M. Wang,
P. F. Richardson and H. C. Kolb, Tetrahedron, 2004, 60,
9043–9048; (d) F. Benfatti, G. Cardillo, L. Gentilucci,
A. Tolomelli, M. Monari and F. Piccinelli, Adv. Synth.
Catal., 2007, 349, 1256–1264; (e) J. L. García Ruano and
C. García Paredes, Tetrahedron Lett., 2000, 41, 5357–5361;
(f ) F. Li, Z.-H. Wang, L. Zhao and F.-E. Chen, Synlett, 2011,
2883–2885.
25 Representative HPLC chromatograms are available in the
ESI.†
26 Additional information on the commercial enzyme
preparations by Prozomix, Ltd. can be found in the ESI† or
online at http://www.prozomix.com/.
27 Additional information on the commercial enzyme prep-
arations by Codexis, Inc. can be found in the ESI† or online
at http://www.codexis.com/.
28 O. Kaplan, A. B. Vesela, A. Petříčková, F. Pasquarelli,
M. Pičmanová, A. Rinágelová, T. C. Bhalla, M. Pátek and
L. Martínková, Mol. Biotechnol., 2013, 54, 996–1003.
29 D. Zhu, C. Mukherjee, E. R. Biehl and L. Hua, J. Biotechnol.,
2007, 129, 645–650.
30 D. Zhu, C. Mukherjee, Y. Yang, B. E. Rios, D. T. Gallagher,
N. N. Smith, E. R. Biehl and L. Hua, J. Biotechnol., 2008,
133, 327–333.
31 (a) D. G. I. Kingston, A. G. Chaudhary, A. A. L. Gunatilaka
and M. L. Middleton, Tetrahedron Lett., 1994, 35, 4483–
4484; (b) E. Baloglu and D. G. I. Kingston, J. Nat. Prod.,
1999, 62, 1068–1071.
32 (a) A. Petříčková, O. Sosedov, S. Baum, A. Stolz and
L. Martínková, J. Mol. Catal. B: Enzym., 2012, 77, 74–80;
(b) A. B. Veselá, A. Petříčková, P. Weyrauch and
L. Martínková, Biocatal. Biotransform., 2013, 31, 49–56.
33 ee-values/er-values (see ref. 37) were determined by chiral
HPLC, methods and representative chromatograms are
available in the ESI.†
34 M. Winkler, A. Glieder and N. Klempier, Chem. Commun.,
2006, 1298–1300.
35 Selected references: (a) N. Layh and A. Willets, Biotechnol.
Lett., 1998, 20, 329–331; (b) P. Kaul and U. C. Banerjee,
J. Ind. Microbiol. Biotechnol., 2008, 35, 713–720;
(c) Z.-J. Zhang, J. Pan, J.-F. Liu, J.-H. Xu, Y.-C. He and
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2015 Org. Biomol. Chem.
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
2/
07
/2
01
5 
16
:5
2:
58
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Y.-Y. Liu, J. Biotechnol., 2011, 152, 24–29; (d) C. Vergne-Vax-
elaire, F. Bordier, A. Fossey, M. Besnard-Gonnet, A. Debard,
A. Mariage, V. Pellouin, A. Perret, J.-L. Petit, M. Stam,
M. Salanoubat, J. Weissenbach, V. De Berardinis and
A. Zaparucha, Adv. Synth. Catal., 2013, 355, 1763–1779;
(e) A. B. Veselá, A. Křenková and L. Martínková,
BioTech2014, Prague, Czech Republic, 2014, Poster: pro-
duction of (R)-mandelic acid by nitrilases from filamen-
tous fungi – comparison of the co-solvent and fed-batch
setup.
36 Review: G. Carrea and S. Riva, Angew. Chem., Int. Ed., 2000,
39, 2226–2254. Selected references: (a) C. B. Faulds,
M. Pérez-Boada and A. T. Martínez, Bioresour. Technol.,
2011, 102, 4962–4967; (b) Z. Guo, M. K. Y. Wong,
M. R. Hickey, B. P. Patel, X. Qian and A. Goswami, Org.
Process Res. Dev., 2014, 18, 774–780; (c) H. J. Park, J. C. Joo,
K. Park, Y. H. Kim and Y. J. Yoo, J. Biotechnol., 2013, 163,
346–352; (d) J. Kuper, T. Seng, D. Roccatano, M. Wilmanns
and U. Schwaneberg, J. Am. Chem. Soc., 2007, 129, 5786–
5787; (e) T. Gerhards, U. Mackfeld, M. Bocola,
E. von Lieres, W. Wiechert, M. Pohl and D. Rother, Adv.
Synth. Catal., 2012, 354, 2805–2820; (f ) T. Koudelakova,
R. Chaloupkova, J. Brezovsky, Z. Prokop, E. Sebestova,
M. Hesseler, M. Khabiri, M. Plevaka, D. Kulik, I. Kuta
Smatanova, P. Rezacova, R. Ettrich, U. T. Bornscheuer and
J. Damborsky, Angew. Chem., Int. Ed., 2013, 52, 1959–
1963.
37 R. E. Gawley, J. Org. Chem., 2006, 71, 2411–2416.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 0
2/
07
/2
01
5 
16
:5
2:
58
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
